Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 4Gastrointestinal 2Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Classical hematology 1

Conditions

Pancreatic Neoplasms 1Fanconi Anemia, Complementation Group D1 1Breast Neoplasms 1

Interventions

Rivaroxaban 8Surveys and Questionnaires 7Heparin, Low-Molecular-Weight 5apixaban 4fludarabine 3Blood Specimen Collection 3pegfilgrastim 2epoetin beta 2Therapeutics 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Observation 2Microarray Analysis 2Melphalan 2Influenza Vaccines 2Immunoenzyme Techniques 2Flow Cytometry 2Epoetin Alfa 2Data Collection 2Dabigatran 2Biopsy 2ziprasidone 1ribociclib 1ravulizumab 1palbociclib 1oprelvekin 1iron isomaltoside 1000 1fludarabine phosphate 1edoxaban 1calcium heparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Genotype × Classical hematology × Clear all
NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Memorial Sloan Kettering Cancer Center

Withdrawn
BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡